Loading organizations...

§ Private Profile · Boston, MA, USA
AI clinical intelligence platform for care teams & post-acute operators, improving care transitions, reducing readmissions.
Headquartered in Boston, Cascala Health provides an AI enabled clinical intelligence platform designed to assist care teams and post acute care operators with care transitions and readmission reductions. The platform integrates directly with web based electronic medical records and population health systems to deliver real time insights and personalized interventions for value based care organizations. This technology manages care for over 300,000 patients across thousands of post acute transitions and is actively utilized by a network of more than 3,000 primary care clinicians. The company has raised over eleven million dollars in total venture funding, including a recent seed round jointly led by Flare Capital Partners and Eniac Ventures alongside strategic backing from Redesign Health and Omega Healthcare Investors. The healthcare technology enterprise was officially established in early 2024 by company founders Matt Murphy, Joseph Jasser, and Himanshu Chaudhary.
Cascala Health has raised $12.0M across 2 funding rounds.
Cascala Health has raised $12.0M in total across 2 funding rounds.
Cascala Health has raised $12.0M across 2 funding rounds. Most recently, it raised $9.0M Seed in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2025 | $9M Seed | Flare Capital Partners, TIM Young | .406 Ventures, ForgePoint Capital, Obvious Ventures, Digital Health Venture Partners, Omega Healthcare Investors, TAU Ventures, Katie Schmitz | Announced |
| Aug 1, 2024 | $3M Seed | — | .406 Ventures, Flare Capital Partners, ForgePoint Capital, Obvious Ventures | Announced |
Cascala Health is a Boston-based healthcare technology company that builds an AI-enabled clinical intelligence platform designed to improve care coordination during patient transitions, especially in post-acute care settings such as skilled nursing and home health. Its platform integrates seamlessly with over 90% of electronic medical records (EMRs) and population health tools, delivering real-time, personalized insights and communication tools directly into clinicians’ workflows. By aggregating and summarizing complex patient data, Cascala helps care teams reduce administrative burdens, close care gaps proactively, and make evidence-based decisions that improve outcomes and efficiency[1][2][3].
The company serves care teams involved in managing chronic diseases and value-based care programs, addressing the critical problem of fragmented information and inefficient handoffs in healthcare. Cascala’s AI-driven approach accelerates decision-making and streamlines documentation, enabling care coordinators and clinicians to focus more on patient care. Early customer feedback highlights significant reductions in manual effort and administrative workload, signaling strong growth momentum following its 2024 launch and $8.6 million seed funding[1][4].
Cascala Health was founded in early 2024, emerging from the recognition that care transitions—the handoffs between hospital, post-acute, and home care—are pivotal yet often poorly coordinated moments in healthcare. The founding team, supported initially by investors like Redesign Health and Flare Capital Partners, sought to embed clinically responsible AI directly into existing workflows to enhance clarity and continuity of care. Early traction came from partnerships with post-acute care providers who experienced measurable improvements in workflow efficiency and patient risk management, validating the platform’s approach[1].
Cascala Health is riding the growing trend of AI integration in healthcare, particularly in the under-addressed post-acute care segment where care fragmentation and data silos are major challenges. The timing is critical as healthcare systems increasingly shift toward value-based care models that reward improved outcomes and cost efficiency. Cascala’s platform leverages advances in AI and interoperability standards to address these market forces, positioning itself as a key enabler of smarter, more coordinated care transitions. Its influence extends to improving population health management and reducing hospital readmissions, thereby impacting the broader healthcare ecosystem[1][4].
Looking ahead, Cascala Health is poised to expand its footprint across more post-acute care providers and deepen its AI capabilities to cover additional clinical specialties and care scenarios. Trends such as increased regulatory focus on care coordination, rising adoption of AI in clinical workflows, and the growing demand for integrated care solutions will likely shape its trajectory. As the company scales, it may also influence standards for AI transparency and clinical decision support in healthcare technology. Cascala’s focus on embedding actionable intelligence at the point of care positions it well to become a critical player in transforming how care transitions are managed, ultimately improving patient outcomes and operational efficiency[1][3].
Cascala Health has raised $12.0M in total across 2 funding rounds.
Cascala Health's investors include Flare Capital Partners, Tim Young, .406 Ventures, Forgepoint Capital, Obvious Ventures, Digital Health Venture Partners, Omega Healthcare Investors, Tau Ventures, Katie Schmitz.